98 related articles for article (PubMed ID: 15766587)
1. Nucleotide-excision repair and prostate cancer risk.
Lockett KL; Snowhite IV; Hu JJ
Cancer Lett; 2005 Apr; 220(2):125-35. PubMed ID: 15766587
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study.
Hu Z; Shao M; Yuan J; Xu L; Wang F; Wang Y; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jin G; Huo X; Chen F; Jin L; Wei Q; Huang W; Lu D; Wu T; Shen H
Carcinogenesis; 2006 Jul; 27(7):1475-80. PubMed ID: 16522664
[TBL] [Abstract][Full Text] [Related]
3. Exploration of methods to identify polymorphisms associated with variation in DNA repair capacity phenotypes.
Jones IM; Thomas CB; Xi T; Mohrenweiser HW; Nelson DO
Mutat Res; 2007 Mar; 616(1-2):213-20. PubMed ID: 17145065
[TBL] [Abstract][Full Text] [Related]
4. Deficient nucleotide excision repair capacity enhances human prostate cancer risk.
Hu JJ; Hall MC; Grossman L; Hedayati M; McCullough DL; Lohman K; Case LD
Cancer Res; 2004 Feb; 64(3):1197-201. PubMed ID: 14871857
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
Ritchey JD; Huang WY; Chokkalingam AP; Gao YT; Deng J; Levine P; Stanczyk FZ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1703-9. PubMed ID: 16030105
[TBL] [Abstract][Full Text] [Related]
6. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the nucleotide excision repair pathway and colorectal cancer risk.
Berndt SI; Platz EA; Fallin MD; Thuita LW; Hoffman SC; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2263-9. PubMed ID: 17119055
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.
Kiyohara C; Takayama K; Nakanishi Y
Lung Cancer; 2006 Dec; 54(3):267-83. PubMed ID: 16982113
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide excision repair pathway genes and oral premalignant lesions.
Wang Y; Spitz MR; Lee JJ; Huang M; Lippman SM; Wu X
Clin Cancer Res; 2007 Jun; 13(12):3753-8. PubMed ID: 17575242
[TBL] [Abstract][Full Text] [Related]
10. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
Shaik AP; Jamil K; Das P
Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
[TBL] [Abstract][Full Text] [Related]
11. [Repair of DNA damage using nucleotide excision repair (NER)--relationship with cancer risk].
Butkiewicz D; Rusin M; Pawlas M; Czarny M; Chorazy M
Postepy Hig Med Dosw; 2002; 56(4):485-98. PubMed ID: 12418414
[TBL] [Abstract][Full Text] [Related]
12. DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil.
Dufloth RM; Costa S; Schmitt F; Zeferino LC
Genet Mol Res; 2005 Dec; 4(4):771-82. PubMed ID: 16475125
[TBL] [Abstract][Full Text] [Related]
13. Estimating the effect of human base excision repair protein variants on the repair of oxidative DNA base damage.
Sokhansanj BA; Wilson DM
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1000-8. PubMed ID: 16702383
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal.
Clarkson SG; Wood RD
DNA Repair (Amst); 2005 Sep; 4(10):1068-74. PubMed ID: 16054878
[TBL] [Abstract][Full Text] [Related]
15. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
[TBL] [Abstract][Full Text] [Related]
16. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
[TBL] [Abstract][Full Text] [Related]
18. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of DNA repair genes are risk factors for prostate cancer.
Hirata H; Hinoda Y; Tanaka Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Majid S; Vejdani K; Dahiya R
Eur J Cancer; 2007 Jan; 43(2):231-7. PubMed ID: 17196815
[TBL] [Abstract][Full Text] [Related]
20. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.
Manuguerra M; Saletta F; Karagas MR; Berwick M; Veglia F; Vineis P; Matullo G
Am J Epidemiol; 2006 Aug; 164(4):297-302. PubMed ID: 16707649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
